2.83
price up icon1.43%   0.04
after-market Handel nachbörslich: 2.83
loading

Finanzdaten der Achieve Life Sciences Inc-Aktie (ACHV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
5.50%
6.707
7.097 7.296 7.609 5.113
Costs And Expenses
2.57%
12.56
12.89 12.19 12.47 8.431
Depreciation and Amortization
11.29%
0.055
0.062 0.058 0.057 0.057
Nonoperating Income/Loss
331.34%
-0.155
0.067 -0.17 -0.046 -0.03
Income/Loss From Continuing Operations Before Tax
2.06%
-12.56
-12.83 -12.36 -12.47 -8.461
Income/Loss From Continuing Operations After Tax
0.85%
-12.72
-12.83 -12.36 -12.51 -8.461
Net Income/Loss
0.85%
-12.72
-12.83 -12.36 -12.51 -8.461
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
34.69
34.69 0.8191 34.36 34.32
Diluted Average Shares
0.00%
34.69
34.69 0.8191 34.36 34.32
Basic Earnings Per Share
0.00%
-0.37
-0.37 -0.36 -0.36 -0.25
Diluted Earnings Per Share
0.00%
-0.37
-0.37 -0.36 -0.36 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):